Introduction: The Hormone You've Overlooked

When you hear "melatonin," you probably think of sleep. But here's what most people don't know: your body uses melatonin for far more than helping you rest. This powerful hormone is a cellular defender that protects your heart, regulates your metabolism, shields your brain from degeneration, and influences how quickly you age. Yet, there's a crisis happening in your body right now that most people never hear about.

Your body produces 90% less melatonin at age 80 than it did in your teenage years. That's a tenfold decline in one of your most important protective substances. Understanding melatonin's full role in your health (and what happens when levels drop) could explain why so many age-related diseases begin to appear in middle and later life.

This article explores what recent research actually shows about melatonin's health benefits beyond sleep, the critical safety concerns that emerged in 2025, practical guidance on whether supplementation makes sense, and why natural production might be your safest option.

What Is Melatonin, Really?

Melatonin is a hormone produced by your pineal gland, a tiny pea-sized gland deep in your brain. When darkness falls, this gland releases melatonin into your bloodstream. The hormone circulates through your body, signalling cells that it's time to prepare for sleep. But melatonin isn't just a sleep signal; it's a sophisticated biochemical protector.

Your body produces melatonin in response to circadian rhythms (your natural 24-hour cycle), but the amount you produce depends partly on genetics and dramatically on age. Unlike some hormones that remain relatively stable across your lifespan, melatonin declines sharply as you age, with the steepest drops after age 50.¹

Part 1: Your Body's Antioxidant Shield

Every second of your life, your cells are producing harmful molecules called free radicals, unstable oxygen molecules that damage cells. This damage accumulates and drives ageing, inflammation, and disease. Think of free radicals as cellular rust.

Your body has natural defences against this rust, but they weaken with age. Melatonin works as a cellular bodyguard in two ways. First, it directly disarms free radicals, neutralising them before they can cause damage. Second, it stimulates your body's own antioxidant defence enzymes: the proteins that patrol your cells looking for damage.²

What makes melatonin unique among antioxidants is that it crosses into your mitochondria, the energy factories inside your cells. Most antioxidants can't reach this critical location, but melatonin does, providing protection exactly where it's needed most.²

Why This Matters for You

The accumulation of oxidative damage is the foundation of ageing and disease. Research confirms that melatonin's antioxidant action is real and operates through multiple protective pathways.¹ However, here's the critical part: at age 80, your body has lost 90% of this protection. Most chronic diseases (heart disease, cancer, diabetes, Alzheimer's) involve oxidative damage as a major component. When melatonin levels drop, your cellular defences become increasingly vulnerable.

This doesn't mean low melatonin causes disease, but it does mean your cells have lost a significant protective resource at the exact time you need it most.

Part 2: Immune System Protection

Your immune system doesn't work the same 24 hours a day. It follows a circadian rhythm guided by melatonin. When melatonin is high (at night), your immune cells are more active. This circadian synchronisation is crucial; when you have poor sleep and low melatonin, your immune defences falter.³

Melatonin acts as an "immune buffer," capable of both stimulating immunity when your body is vulnerable and calming excessive inflammation when immunity becomes overactive. When immunity is weak, melatonin increases production of infection-fighting cells including natural killer cells (your first line of defence against viruses), macrophages (immune cells that engulf pathogens), and T-cells (your army of immune specialists).³

The Evidence: Dramatic in Animals, Limited in Humans

Animal studies show striking protection. In mice infected with Venezuelan equine encephalomyelitis (a normally fatal virus), untreated mice had 100% mortality, whilst melatonin-treated mice had only 16% mortality: an 84 percentage point reduction in death rate.³ This demonstrates melatonin can dramatically enhance immune protection against serious infections.

However, translating this to human clinical practice remains incomplete. Most evidence for melatonin's immune benefits comes from laboratory studies and mechanistic research, not from human prevention trials. We can confirm melatonin stimulates immune cells, but we haven't yet conducted large prospective studies proving melatonin supplementation prevents infection in humans.

Why This Matters for You

Your immune system is your primary defence against infection, cancer, and age-related diseases. The connection between sleep quality, melatonin levels, and immunity is well-established: chronic sleep loss increases infection risk.³ This suggests that maintaining healthy melatonin levels through consistent sleep is genuinely protective. Whether supplemental melatonin provides additional immune benefits remains an important unanswered question.

Part 3: Cardiovascular Health: A Conflicting Picture

This is where the melatonin story becomes complicated. Laboratory research shows convincing cardioprotective mechanisms. Melatonin reduces nocturnal blood pressure in people with hypertension, prevents heart cell death during ischaemia (oxygen deprivation; common during heart attacks) and may prevent the heart enlargement that leads to heart failure.⁴

A 2024 study of elderly patients with sleep disorders found that long-term high-dose melatonin (40-200 mg daily) was well tolerated and associated with improvements in blood pressure control, heart disease, and metabolic markers.⁴

The 2025 Safety Alarm

But new 2025 research contradicts everything above. A large multinational real-world cohort study presented preliminary findings showing that long-term melatonin supplementation in people with insomnia was associated with:

• 89% higher hazard of developing heart failure⁴
• 3-fold increase in heart failure-related hospitalisation⁴
• Doubling of all-cause mortality over 5 years⁴

These findings are alarming and deserve careful attention. However, they require important context: this is observational data (not a controlled experiment), so it cannot prove that melatonin causes heart problems. It only shows association. People who take melatonin long-term might already have underlying conditions that increase cardiac risk. The study also hasn't yet been peer-reviewed.

The Unresolved Question

Here's the troubling scientific contradiction: laboratory and mechanistic evidence suggests melatonin should protect the heart. Real-world data suggests long-term supplementation may harm it. Until this contradiction is resolved through prospective clinical trials, the safest approach is caution with long-term supplementation, especially in people with cardiac risk factors.⁴

 Figure 1: Five-year cardiovascular outcomes in long-term melatonin users versus controls. New 2025 data shows associations with heart failure, hospitalisation and mortality. Important note: This observational data cannot prove causation and requires further investigation.⁴

Part 4: Metabolic Health and Blood Sugar Control

Your metabolism depends partly on melatonin. People with specific genetic variants in the MTNR1b gene (which codes for a melatonin receptor) have an increased risk of high blood sugar and type 2 diabetes.⁵ This genetic evidence shows melatonin has a fundamental role in how your body handles glucose.

Melatonin works on multiple metabolic pathways. It stimulates your pancreas to produce both insulin (which lowers blood sugar) and glucagon (which prevents blood sugar from dropping too low). However, timing is critical: high melatonin combined with food intake decreases glucose tolerance; blood sugar rises higher and stays elevated longer. This means eating late at night when melatonin is high may be metabolically worse than eating earlier in the day.⁵

Mixed Clinical Evidence

Research on melatonin and diabetes is genuinely contradictory. A meta-analysis of 16 randomised clinical trials found that 56% of studies showed diabetes benefits, but 44% showed no significant improvement in insulin resistance. Most studies found no significant improvement in HbA1c (the standard blood sugar control marker).⁵

Even more concerning, some research shows melatonin may worsen glucose tolerance. One acute dosing study found melatonin increased morning glucose by 186% above placebo levels and evening glucose by 54%; the opposite of what's desired for someone with diabetes.⁵

Why This Matters for You

If you have diabetes or metabolic dysfunction, don't take melatonin expecting to improve blood sugar without discussing it with your doctor. The evidence is too mixed. However, if you're taking melatonin for sleep, large prospective population studies suggest long-term use isn't associated with increased diabetes risk, so don't panic if you're already using it.⁵

The key insight: maintaining good sleep quality (which naturally supports healthy melatonin production) is metabolically protective. This is better established than supplemental melatonin benefits.

Part 5: Brain Protection and Cognitive Health

Your brain is exquisitely vulnerable to oxidative damage and inflammation. Melatonin crosses the blood-brain barrier (unlike most antioxidants) and protects brain tissue through multiple mechanisms: directly neutralising free radicals, reducing neuroinflammation, preventing brain cell death and enhancing the lymphatic system (your brain's waste removal pathway that clears toxic proteins).⁶

Notably, melatonin levels are abnormally low in people with Alzheimer's disease and Parkinson's disease before diagnosis. This suggests the hormone decline may contribute to disease development, not just be a symptom.⁶

Clinical Trial Evidence

A placebo-controlled trial gave mild-to-moderate Alzheimer's patients 2 mg of prolonged-release melatonin for 6 months. The results showed significantly better cognitive performance and better sleep efficiency: meaningful improvements in brain function, not just sleep.⁶

In Parkinson's disease, 12 weeks of melatonin supplementation showed favourable effects on multiple scales simultaneously: motor symptoms (measured by the UPDRS, the Unified Parkinson's Disease Rating Scale), sleep quality, depression severity and anxiety.⁶

The Limitation

Most strong evidence for melatonin's brain protection comes from animal studies and cellular models. Human clinical trials in cognitive decline are limited but promising. We need larger, longer-duration studies to know whether melatonin can prevent cognitive decline in people at genetic risk, or whether it works best as a treatment for established disease.

Why This Matters for You

If you have early cognitive concerns or family history of Alzheimer's, the evidence suggests melatonin might be helpful; but supporting natural melatonin production through good sleep is a more evidence-based approach. If you already have Alzheimer's or Parkinson's disease, clinical evidence supports considering melatonin as an adjunctive therapy under medical supervision.⁶

 Figure 2: Melatonin production declines approximately 90% from teenage years to age 80, leaving the brain increasingly vulnerable to degeneration.¹

Part 6: Anti-Inflammatory Effects: One of the Strongest Benefits

Chronic inflammation is the foundation of most modern diseases: heart disease, diabetes, cancer, arthritis, Alzheimer's and autoimmune conditions. Melatonin reduces inflammation through multiple pathways, particularly by blocking the NF-κB pathway: the master switch that turns on inflammatory genes.⁷

A meta-analysis of clinical trials found melatonin significantly reduced four major inflammatory markers:

• Interleukin-1 (IL-1): Significant reduction⁷
• Interleukin-6 (IL-6): Significant reduction⁷
• Interleukin-8 (IL-8): Significant reduction⁷
• Tumour necrosis factor (TNF): Significant reduction⁷

Interestingly, melatonin did NOT significantly reduce C-reactive protein (CRP), another major inflammation marker. This suggests melatonin targets specific inflammatory pathways but not all inflammation mechanisms.⁷

Clinical Significance

The fact that melatonin reduces multiple inflammatory cytokines simultaneously is meaningful. Most anti-inflammatory drugs block a single pathway; melatonin addresses several at once. This multi-targeted approach could explain why melatonin shows clinical benefits in inflammatory conditions: it's not relying on a single inflammation mechanism.

Why This Matters for You

Inflammation drives most chronic diseases. If melatonin can reduce multiple inflammatory markers, it could help prevent or slow progression of conditions including cardiovascular disease, type 2 diabetes, rheumatoid arthritis and cognitive decline.⁷ The evidence for anti-inflammatory effects is among the strongest for melatonin's non-sleep benefits.

 Figure 3: Meta-analysis results showing melatonin's effects on inflammatory markers. Melatonin significantly reduces four major cytokines (IL-1, IL-6, IL-8, TNF) but does not affect C-reactive protein (CRP).⁷

Part 7: Supplemental Evidence: IBS, Bone Health and Cancer Research

Gastrointestinal Health

For irritable bowel syndrome (IBS), the evidence is genuinely encouraging. A meta-analysis of four randomised trials with 115 total participants found melatonin significantly improved IBS severity, abdominal pain and quality of life compared to placebo.⁸ This is one of the most consistent positive findings across melatonin research. For inflammatory bowel disease (ulcerative colitis and Crohn's), melatonin showed similar benefits with improved inflammation markers and quality of life.⁸

Bone Health

Bone mineral density is a concern, especially for postmenopausal women. When combined with vitamin D3 and vitamin K2, melatonin showed 2-4% increases in bone density over 12 months, along with improved bone turnover markers.⁸ Melatonin isn't yet used clinically for osteoporosis, but early evidence suggests it could be a useful complementary therapy.

Cancer Research

46 clinical trials are currently investigating melatonin as an adjunctive cancer therapy (add-on to chemotherapy, not a replacement). As of early 2024, 52% of trials are completed, 11% are actively recruiting and 0% have been approved by regulators.⁸ Melatonin shows promise as a therapy that might enhance chemotherapy effectiveness and improve quality of life in cancer patients, but it remains in the research phase. Do not use melatonin for cancer treatment outside of approved clinical trials.

Part 8: The Quality Control Crisis

Here's a critical problem that undermines everything: 71% of melatonin supplements don't contain the dose claimed on the label.⁹ Products labelled '5 mg' might contain anywhere from 2 mg to 25 mg: a tenfold difference. Even worse, 88% of melatonin gummies are inaccurately labelled, and content can vary by as much as 465% between different batches of the same product.⁹

Additionally, more than 25% of melatonin products contain unlabelled serotonin, a neurotransmitter that can cause serious side effects, especially when combined with certain medications (potentially causing serotonin syndrome).⁹

How to Ensure Quality

• Look for the "USP Verified" mark, which certifies that products contain what the label claims and are free from harmful contaminants
• Choose products tested by third parties (ConsumerLab.com, NSF International, Underwriters Laboratories)
• Select products labeled "GMP" (Good Manufacturing Practices)
• Choose formulations with fewest ingredients (simpler products show greater consistency)
• Purchase from reputable manufacturers with transparent quality control

This quality crisis reveals a fundamental problem: the FDA doesn't regulate dietary supplements as rigorously as pharmaceutical drugs. You cannot assume the melatonin you purchase contains the dose on the label.

 Figure 4: Quality control failures in melatonin supplements. The vast majority of products don't contain what the label claims and contamination is common.⁹

Part 9: Melatonin for Sleep: What the Research Actually Shows

Let's address the original reason most people use melatonin. Clinical trials show melatonin produces modest improvements: reducing sleep onset time by approximately 7 minutes and increasing total sleep by 8 minutes on average.¹⁰ This is noticeable but not dramatic. If you normally take 45 minutes to fall asleep, melatonin would reduce that to about 38 minutes.

Sleep quality improvements are more significant, with people reporting better sleep on standard measurement scales. Melatonin is most effective for circadian rhythm disorders (like Delayed Sleep-Wake Phase Disorder) and less effective for primary insomnia in adults.¹⁰

The Official Medical Stance

Interestingly, the American Academy of Sleep Medicine does NOT recommend melatonin as first-line treatment for insomnia in adults, noting that evidence of effectiveness is limited. The preferred treatment is cognitive behavioural therapy for insomnia (CBT-I), which shows superior long-term results.¹⁰

Recommended Dosing

• Adults (18-64): Start with 0.5-1 mg, take 30-60 minutes before desired bedtime. Typical effective dose is 1-3 mg. Maximum 10 mg per day
• Older adults (65+): Start much lower at 0.3-0.5 mg, with a maximum of 2 mg. Consult your doctor first
• Important principle: Research suggests dosages below 1 mg may work as well as higher doses. Above 2-3 mg, you're unlikely to get additional benefit¹⁰

Part 10: Safety, Side Effects, and Drug Interactions

Short-Term Safety (1-2 months)

For short-term use, melatonin is generally safe for most people. The most common side effects are drowsiness and headaches. Less common side effects include vivid dreams, nausea, dizziness and mild mood changes. Side effects are usually mild and resolve when you stop taking melatonin.¹¹

Melatonin is not habit-forming and doesn't cause tolerance (you don't need increasing doses over time).

Long-Term Safety: The Key Uncertainty

Here's the critical gap in knowledge: long-term safety of melatonin supplements (beyond 2-3 years) has not been well-studied. Most research focuses on short-term use. The 2025 cardiovascular data we discussed earlier (showing increased heart failure risk with long-term use) is preliminary but concerning enough to warrant caution.

Drug Interactions

Research has identified 353 drugs that interact with melatonin: 5 major interactions, 339 moderate interactions and 9 minor interactions.¹¹ Before starting melatonin, discuss it with your pharmacist if you take:

• CNS depressants (benzodiazepines, opioids, antihistamines, alcohol, barbiturates): melatonin amplifies drowsiness and cognitive impairment
• Blood pressure medications: may worsen blood pressure control
• Diabetes medications: increased risk of low blood sugar
• Antidepressants (especially fluvoxamine): may increase melatonin levels excessively
• Blood thinners: may increase bleeding risk
• Immunosuppressant medications: melatonin stimulates immunity, potentially reducing drug effectiveness

Populations That Should Avoid Melatonin

• Pregnant or breastfeeding: Insufficient safety data; avoid unless specifically recommended by your obstetrician
• Dementia: The American Academy of Sleep Medicine recommends against melatonin in this population due to increased risk of confusion and falls
• Autoimmune disease: Melatonin activates immunity, potentially worsening autoimmune symptoms
• Uncontrolled diabetes: Blood sugar effects are unpredictable
• Age 65+: Must consult a doctor first. Limited safety research in older adults; higher risk of side effects and falls

Part 11: Should You Use Melatonin Supplements?

When to Consider Melatonin

• Occasional jet lag: especially for business travellers
• Temporary sleep disruption: recovery from surgery or acute stress
• Shift work sleep problems: when properly timed
• Circadian rhythm disorders: under medical supervision with precise timing
• Alzheimer's or Parkinson's disease: as adjunctive therapy under medical supervision

When to Avoid or Use Caution

• Chronic insomnia: cognitive behavioural therapy is more effective and safer long-term
• Long-term nightly use: insufficient safety data; emerging cardiovascular concerns
• High-dose supplementation: higher doses don't improve effectiveness and increase risk
• General health optimisation in healthy people: supporting natural melatonin production is better

The Safer Alternative: Supporting Natural Melatonin

Rather than supplementation, optimise natural melatonin production through:

• Consistent sleep schedule: same bedtime and wake time daily (even weekends)
• Light exposure: 15–30 minutes of bright light in the morning; complete darkness at night
• Circadian alignment: eat during daylight hours; avoid late-night eating
• Quality sleep: 7–9 hours nightly
• Stress management: chronic stress suppresses melatonin production

These approaches support all of melatonin's protective functions without supplement risks.

Part 12: Practical Guidance Before You Start

Step 1: Self-Assessment

Before considering melatonin, ask yourself:

• Do I have a documented sleep disorder or circadian rhythm problem?
• Have I tried non-medication approaches (sleep hygiene, cognitive behavioural therapy)?
• Do I have any conditions that contraindicate melatonin (dementia, autoimmune disease, pregnancy)?
• Am I taking other medications or supplements?

Step 2: Medical Consultation

If you're over 65, pregnant, breastfeeding, or have any health conditions, consult your doctor first. Bring a complete medication list.

Step 3: Pharmacist Review

Show your pharmacist all medications and supplements. They specialise in drug interactions and can identify risks your doctor might miss.

Step 4: Product Quality

If you proceed with supplementation:

• Choose USP Verified or third-party tested products
• Start with 0.5 mg and give your body 3-5 days to respond before increasing
• Find your minimum effective dose (lower is better)
• Use immediate-release formulations for sleep (not extended-release)
• Take 30-60 minutes before bedtime, not with food

Step 5: Duration and Monitoring

• Limit initial use to 1-2 months
• If continuing beyond 2 months, discuss with your doctor every 3-6 months
• If considering long-term use, discuss the 2025 cardiovascular safety findings with your doctor

The Bottom Line: Making an Informed Choice

Melatonin is genuinely a multi-system protector with documented benefits for antioxidant defence, immune regulation, inflammation reduction and brain protection. However, the translation from laboratory findings to proven clinical benefits in humans remains incomplete. The evidence is strongest for sleep improvement (though modest) and possibly for Alzheimer's and Parkinson's disease as adjunctive therapy.¹

The emerging 2025 safety data showing increased cardiovascular risk with long-term use has complicated recommendations significantly. Until this contradiction is resolved through proper clinical trials, the safest approach is:

1. Support natural melatonin production through optimised sleep habits
2. Consider supplementation for specific, short-term uses (jet lag, temporary sleep disruption, circadian disorders) under medical guidance
3. Avoid long-term supplementation unless specifically recommended by a doctor for a particular condition
4. Never use melatonin as a substitute for proven treatments like cognitive behavioural therapy for insomnia

The paradox of melatonin is this: your body produces this powerful hormone naturally in response to circadian rhythms, and supporting this natural production through sleep hygiene accomplishes what supplements promise: better long-term safety and lower risk. For most people, the most effective strategy is optimising darkness at night, light exposure during the day, consistent sleep timing and stress management. This supports all of melatonin's known protective effects without supplement risks.

When to Seek Additional Help

If sleep problems persist despite lifestyle changes, or if you're interested in melatonin for specific health conditions, consult a sleep specialist or your physician. The field of sleep medicine has evolved significantly, and evidence-based approaches beyond melatonin often produce superior results.

Further Reading

Sleep Health and Circadian Rhythms

• The Role of Melatonin in Circadian Rhythm Sleep-Wake Cycle
• New Perspectives on Melatonin and Human Sleep
• Cognitive Behavioural Therapy for Insomnia (American College of Physicians)

Cardiovascular Health

• Melatonin and Cardiovascular Disease: Evidence and Mechanism
• 2025 American Heart Association Safety Findings
• Heart Health and Sleep Quality

Brain Health and Neuroprotection

• Melatonin in Alzheimer's Disease: Clinical Perspectives
• Neuroprotective Potential in Parkinson's Disease
• Melatonin Cognition and Brain Health in Aging

Metabolic Health and Glucose Control

• Melatonin Signalling and Glucose Homeostasis
• Effects on Insulin Sensitivity and Metabolic Health
• Nocturnal Melatonin and Glucose Tolerance

Anti-Inflammatory and Immune Effects

• Anti-Inflammatory Effects: Systematic Review and Meta-Analysis
• Melatonin as Immune Buffer: Buffering the Immune System
• Sleep Deprivation and Immune Dysregulation

Gastrointestinal Health

• Melatonin Efficacy in Irritable Bowel Syndrome
• Treatment in Ulcerative Colitis and Inflammatory Bowel Disease
• Effects on Gastrointestinal Inflammation

Safety, Quality Control, and Supplementation

• Melatonin Side Effects and Safety Profile
• Supplement Quality Control Crisis
• Serotonin Contamination in Melatonin Products
• Drug Interactions Database

Dosing and Clinical Guidelines

• American Academy of Sleep Medicine Guidelines
• Mayo Clinic Melatonin Information
• Cleveland Clinic Dosing Guidance

Cancer Research

• Melatonin in Cancer Treatment: Current Clinical Trials
• Melatonin as Adjunctive Cancer Therapy

Disclaimer: This article is for informational purposes and should not replace professional medical advice. If you have specific health conditions, are taking medications, or are considering melatonin supplementation, consult your healthcare provider before beginning any new supplement regimen.